Filter
3997
Filtered Results: 3997
Text search:
drug
distribution
Featured
Recommendations
326
New Publications
1153
Language
Document type
No document type
2482
Studies & Reports
647
Guidelines
468
Manuals
159
Strategic & Response Plan
127
Fact sheets
42
Training Material
39
Situation Updates
21
Infographics
7
Brochures
2
Resource Platforms
2
Online Courses
1
Countries / Regions
India
212
Kenya
127
Global
127
Uganda
104
Ethiopia
99
Nigeria
96
South Africa
84
Sierra Leone
77
Tanzania
74
Liberia
74
Nepal
73
Western and Central Europe
73
Malawi
71
Latin America and the Carribbean
61
Zambia
61
Myanmar / Burma
60
Ghana
58
Bangladesh
55
Rwanda
54
Africa
47
Ukraine
43
Namibia
42
Eastern Europe
37
Zimbabwe
36
Philippines
35
Lesotho
30
Cambodia
30
South–East Asia Region
28
Asia
26
Senegal
24
Botswana
23
Congo, Democratic Republic of
20
Russia
20
Indonesia
20
Burkina Faso
19
Mozambique
19
Colombia
16
East and Southern Africa
15
Syria
14
Haiti
14
Eswatini/ Swaziland
13
Venezuela
12
Albania
11
Paraguay
11
South Sudan
11
Thailand
10
Cameroon
10
USA
10
West and Central Africa
10
Benin
9
Middle East and North Africa
9
Brazil
9
Tajikistan
8
Peru
8
Guinea
8
Germany
8
Eastern Europe and Central Asia
8
Pakistan
8
Argentina
7
Sudan
7
Georgia
7
Vietnam
6
Moldova
6
North Macedonia
5
China
5
Laos
5
Afghanistan
5
Bolivia
5
Iraq
5
El Salvador
4
Chile
4
Armenia
4
Spain
4
Sri Lanka
4
Timor Leste/ East Timor
3
Turkey
3
Morocco
3
Jordan
3
Western Pacific Region
3
North America
3
Lebanon
3
Papua New Guinea
3
Bhutan
3
Mexico
2
Iran
2
Fiji
2
Kyrgyzstan
2
Uzbekistan
2
Mongolia
2
Gabon
2
Uruguay
2
Tunisia
2
United Kingdom
2
Portugal
2
Yemen
2
Central African Republic
2
Honduras
2
Libya
2
Madagascar
2
North Korea
1
Serbia
1
Kazakhstan
1
Canada
1
Estonia
1
Bulgaria
1
Hungary
1
Ireland
1
Saudi Arabia
1
Turkmenistan
1
Jamaica
1
France
1
Maldives
1
Mauritius
1
Norway
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Nicaragua
1
Egypt
1
Romania
1
Greece
1
Palestine
1
Mali
1
Angola
1
Chad
1
Somalia
1
Ecuador
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1662
Clinical Guidelines
333
Public Health
206
Women & Child Health
138
Key Resources
113
Pharmacy & Technologies
56
Capacity Building
47
Annual Report MEDBOX
1
Toolboxes
HIV
436
Mental Health
345
TB
317
NTDs
214
AMR
189
COVID-19
156
Pharmacy
146
Rapid Response
69
Caregiver
64
Planetary Health
58
NCDs
58
Ebola & Marburg
50
Refugee
48
Disability
46
Conflict
44
Global Health Education
41
Health Financing Toolbox
34
Natural Hazards
20
Specific Hazards
15
Cholera
15
Polio
15
Zika
14
Malaria
10
Social Ethics
7
Am. J. Trop. Med. Hyg., 106 (Suppl 5), 2022, pp. 56–60. Lymphatic filariasis (LF) is a parasitic disease that is a major cause of chronic disability in the developing world. According to the 2021–2030 road map for neglected tropical diseases (NTDs) published by the World Health Organization (WHO...
In recent years Terre des Hommes Netherlands observed the steady rise of a new form of child sexual exploitation. One that is enabled and fuelled by rapid technological advances, increasing global connectivity, persisting poverty rates, and growing disparity in the global distribution of resources. ...
Guidelines for social mobilization
TB and poverty; TB and children; TB and women; TB, migrants and refugees; TB and prisons
WHO/CDS/STB/2001.9
Original: English; Distribution: Limited
Fever Diagnostic Technology Landscape
recommended
1st edition.
Unitaid’s report describes a slate of new devices that can more efficiently identify dangerously ill children so that they can be treated immediately. These tools make it easier to recognize danger signs, and support integrated approaches to reducing childhood deaths from the three ...
23 décembre 2020 Ce document résume les recommandations de l'OMS concernant l'utilisation rationnelle des équipements de protection individuelle (EPI) dans les établissements de soins de santé et les stratégies temporaires en cas de pénurie aiguë d'approvisionnement. Ce document contient ég...
These guidelines are based on the 3rd Edition of the WHO Guidelines (Published 2015) World Health Organization’s Guidelines for the treatment of malaria. Additional literature surveys have been undertaken. Factors that were considered in the choice of therapeutic options included effectiveness, sa...
This guide to local production of WHO-recommended handrub formulations is separated into two discrete but interrelated sections:
Part A provides a practical guide for use at the pharmacy bench during the actual preparation of the formulation. Users may want to display the material on the wall of ...
The Libyan national action plan has been aligned with WHO five objectives. Analysis of the current situation and addressing the gaps and the needs to reach the main goal “one health” approach involves several national sectors and actors, including human and veterinary health, agriculture and foo...
The global increase of healthcare-associated infections (HAI) presents a growing concern in healthcare worldwide. According to the European Centre for Disease Prevention and Control (ECDC), the annual number of HAI exceeds 2.6million and produces the highest estimated amou...
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of...
This country cooperation strategy (CCS) outlines how the World Health Organization (WHO) will work with the Lao People’s Democratic Republic over the next five years (2024–2028), supporting the implementation of the five-year health sector development plans and the Health Sector Reform Strategy ...
Ahead of World Malaria Day, the WHO Global Malaria Programme published a new operational strategy outlining its priorities and key activities up to 2030 to help change the trajectory of malaria trends, with a view to achieving the global malaria targets. The strategy outlines 4 strategic objectives ...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
There is a broad consensus nowadays that the Earth is warming up as a result of greenhouse gas emissions caused by anthropogenic activities. It is also clear that current trends in the fields of energy, development and population growth will lead to continuous and ever more dramatic climate change. ...
Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, genera...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
Antimicrobial resistance (AMR) has emerged as a major public health problem all over the world. Infections caused by resistant microbes fail to respond to treatment, resulting in prolonged illness and greater risk of death. This document focuses on the mechanism to develop a practically applicable h...
